Open Access Open Access  Restricted Access Subscription or Fee Access

The New Dimension of Cancer: It is Not a Disease but a Deficiency of Vitamin B17

Giri Raja Sekhar, N Sreeja

Abstract


Most commonly used an alternative drug in the treatment of tumor in the last 40 years is Amygdalin. Treatment based on the use of Vitamin B-17, proteolytic pancreatic enzymes, immunostimulants, vitamin and mineral supplements for cancer is a metabolic therapy which is nontoxic. National Cancer Institute is unsuccessful to prove that Laetrile is ineffective and toxic during their studies by clinical trials in 1981. Today, position on the "front lines" of alternative cancer therapy occupied by Amygdalin. Surgery, radiation and chemotherapy can only be administered for a limited time, but Amygdalin can be used indefinitely due to its nontoxicity nature. Combination of Amygdalin with other mineral and vitamin supplements showed effective therapy to treat cancer. Further studies should be conducted to make Laetrile available for the treatment of cancer patients to protect from toxic effects of chemotherapy.

 

Keywords: Amygdalin, Chemotherapy, Radiation, Surgery

 

Cite this Article

Giri Raja Sekhar, N. Sreeja. The New Dimension of Cancer: It is Not a Disease but a Deficiency of Vitamin B17. Research & Reviews: Journal of Oncology & Hematology. 2018; 7(3): 34–36p.


Full Text:

PDF


DOI: https://doi.org/10.37591/rrjooh.v7i3.553

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Research & Reviews: Journal of Oncology and Hematology